Danone Michelin and DMC Biotechnologies Join Forces for Revolutionary Fermentation Center

BIOT

featured image of Danone Michelin and DMC Biotechnologies Join Forces for Revolutionary Fermentation Center
🧪 French dairy company Danone, engineering materials group Michelin, US start-up DMC Biotechnologies, and Crédit Agricole Centre France have collaborated to create the Biotech Open Platform, a precision fermentation center. The platform, located in Clermont-Ferrand, France, aims to support the development of biosolutions at a larger scale. The center will focus on developing cutting-edge fermentation technologies for the food industry. 🥛🧪🌱
📢 Danone Michelin and DMC Biotech Unite for Revolutionary Fermentation Center

Introduction:

French dairy giant Danone, engineering materials group Michelin, US start-up DMC Biotechnologies, and Crédit Agricole Centre France have collaborated to create the Biotech Open Platform, a precision fermentation center. The platform, located in Clermont-Ferrand, aims to support the development of biosolutions at a larger scale and accelerate innovation, health benefits, and decarbonization in the food industry.

Main points:

  1. The Biotech Open Platform is a collaborative effort between Danone, Michelin, DMC Biotechnologies, and Crédit Agricole Centre France.
  2. The platform is focused on precision fermentation and aims to support the development of biosolutions on a larger scale.
  3. The center is located in Clermont-Ferrand at the Parc Cataroux Centre for Sustainable Materials.
  4. Danone has previously invested in precision fermentation companies Imangindairy and Wilk.
  5. The first phase of the platform will involve the installation of a demo-scale production line with a fermenter and purification unit.

Conclusion:

The collaboration between Danone, Michelin, DMC Biotechnologies, and Crédit Agricole Centre France in creating the Biotech Open Platform is a significant step towards advancing precision fermentation and developing biosolutions on a larger scale. This partnership will contribute to accelerating innovation, improving health benefits, and promoting decarbonization in the food industry. The investment in a demo-scale production line demonstrates the commitment of the partners to scaling up innovative products and furthering the development of fermentation technologies.

Leave a Comment